Mark Pollack to Depressive Disorder, Major
This is a "connection" page, showing publications Mark Pollack has written about Depressive Disorder, Major.
Connection Strength
0.819
-
A double-blind, placebo-controlled study of aripiprazole adjunctive to antidepressant therapy among depressed outpatients with inadequate response to prior antidepressant therapy (ADAPT-A Study). Psychother Psychosom. 2012; 81(2):87-97.
Score: 0.394
-
Efficacy of dose increase among nonresponders to low-dose aripiprazole augmentation in patients with inadequate response to antidepressant treatment: a randomized, double-blind, placebo-controlled, efficacy trial. J Clin Psychiatry. 2012 Mar; 73(3):353-7.
Score: 0.096
-
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol. 2008 Mar; 18(3):230-3.
Score: 0.072
-
Preventing recurrent depression: long-term treatment for major depressive disorder. J Clin Psychiatry. 2007 Mar; 68(3):e06.
Score: 0.070
-
Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample. Depress Anxiety. 2005; 21(2):55-60.
Score: 0.060
-
Moderating effects of major depression on patterns of comorbidity in patients with panic disorder. Psychiatry Res. 2004 Apr 30; 126(2):143-9.
Score: 0.058
-
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
Score: 0.019
-
Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. J Anxiety Disord. 2007; 21(7):888-902.
Score: 0.017
-
Effects of parental anxiety disorders in children at high risk for panic disorder: a controlled study. J Affect Disord. 2006 Aug; 94(1-3):191-7.
Score: 0.017
-
Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry. 2006 Jan-Mar; 18(1):33-42.
Score: 0.016